N-Methyl amisulpride

TargetMol
Product Code: TAR-T33703
Supplier: TargetMol
CodeSizePrice
TAR-T33703-10mg10mg£338.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33703-50mg50mg£884.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33703-100mg100mg£1,457.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
N-Methyl amisulpride is an impurity of Amisulpride.
CAS:
1391054-22-0
Formula:
C18H29N3O4S
Molecular Weight:
383.51
Purity:
0.98
SMILES:
CCN1CCCC1CN(C)C(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC

References

Gan TJ, Kranke P, Minkowitz HS, Bergese SD, Motsch J, Eberhart L, Leiman DG, Melson TI, Chassard D, Kovac AL, Candiotti KA, Fox G, Diemunsch P. Intravenous Amisulpride for the Prevention of Postoperative Nausea and Vomiting: Two Concurrent, Randomized, Double-blind, Placebo-controlled Trials. Anesthesiology. 2017 Feb;126(2):268-275. doi: 10.1097/ALN.0000000000001458. PubMed PMID: 27902493. Arora M, Banal R, Praharaj SK, Mahajan V. Amisulpride Augmentation in Acute Catatonia. Am J Ther. 2017 Jul/Aug;24(4):e381-e385. doi: 10.1097/MJT.0000000000000311. PubMed PMID: 26270797. Barnes TR, Leeson VC, Paton C, Marston L, Davies L, Whittaker W, Osborn D, Kumar R, Keown P, Zafar R, Iqbal K, Singh V, Fridrich P, Fitzgerald Z, Bagalkote H, Haddad PM, Husni M, Amos T. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness. Health Technol Assess. 2017 Sep;21(49):1-56. doi: 10.3310/hta21490. PubMed PMID: 28869006; PubMed Central PMCID: PMC5601255. Herrstedt J, Summers Y, Daugaard G, Christensen TB, Holmskov K, Taylor PD, Fox GM, Molassiotis A. Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study. Support Care Cancer. 2018 Jan;26(1):139-145. doi: 10.1007/s00520-017-3825-2. Epub 2017 Aug 11. PubMed PMID: 28801850.